Design Therapeutics, Inc. DSGN Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Design Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Design Therapeutics, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Design Therapeutics, Inc.'s accounts payable?
- Design Therapeutics, Inc. (DSGN) reported accounts payable of $2.28M in Q1 2026.
- How has Design Therapeutics, Inc.'s accounts payable changed year-over-year?
- Design Therapeutics, Inc.'s accounts payable decreased by 28.4% year-over-year, from $3.18M to $2.28M.
- What is the long-term trend for Design Therapeutics, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Design Therapeutics, Inc.'s accounts payable has grown at a 10.6% compound annual growth rate (CAGR), from $1.4M to $2.31M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.